about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesEpigenetic modulation as a therapeutic approach for pulmonary arterial hypertensionPathobiology of pulmonary arterial hypertension and right ventricular failureMolecular mechanisms of pulmonary arterial remodelingBeyond the genome: epigenetic mechanisms in lung remodelingmiR-127 protects proximal tubule cells against ischemia/reperfusion: identification of kinesin family member 3B as miR-127 targetThe emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series)Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesRole of epigenetics in pulmonary hypertensionMicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblastsDiverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype.TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertensionIdentification of functional progenitor cells in the pulmonary vasculature.Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis.The role of redox signaling in epigenetics and cardiovascular disease.Genetics and epigenetics of arrhythmia and heart failure.Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells.The role of hypoxia in pulmonary vascular diseases: a perspective.Epigenetics: novel mechanism of pulmonary hypertension.Novel and emerging therapies for pulmonary hypertension.The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.Connexin-mediated regulation of the pulmonary vasculature.Novel investigational therapies for treating pulmonary arterial hypertension.Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.Molecular pathogenesis and current pathology of pulmonary hypertension.DNA methylation and hypertension: emerging evidence and challenges.Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca2+-activated K+ channel function in ovine uterine arteries.Emerging Therapeutics in Pulmonary Hypertension.Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension.[Genetics and epigenetics. Explanatory approaches for (gender-specific) mechanisms of disease development].DNA Methylation and Histone Modification in Hypertension.
P2860
Q21284678-94CAC0A6-EEF6-4313-8056-A1771EDCE0DCQ26801345-DC3C46C6-9444-4576-9ABC-C5F51DFB2BD8Q26821779-3E6AC63A-DEF9-4E55-8FD1-2E42A49FF30DQ26991806-51DF488B-71B2-4A05-B465-287E81ADE8B8Q27021767-7C215F23-47B2-460D-A687-93CD76D8A91BQ27320810-E3807C4D-A01A-4257-8DE4-3D3738FA83F3Q28069443-7B76DBC1-E62A-4B52-809F-8CB805ECF2A8Q30570945-8EC8C24B-97F1-469A-9D6F-C73FF9FA364FQ33764713-BC588561-BDCB-4E74-9689-F4BCC5C9E6DAQ33982509-AB2CD499-7B71-4AAA-92B1-F4168313E199Q34001699-B218973B-1567-4F56-B545-D6D10338A712Q34339756-577C4AFD-64A4-40AE-BB38-6D2D62806CE3Q35929780-C391E6F7-4146-4C9A-B69B-D3E2E58BF1B8Q36352101-22C08DE8-6496-4544-A84C-5709C764A0AFQ36761147-8F680215-847C-4F45-B42D-FBFDBF3F5668Q37267318-85F3A74C-645A-4DF1-B0C5-957BC1E5C8CEQ37524525-1FAAAF9D-2832-4351-BF9F-3240FF178663Q38078782-522CC2A4-0307-4E20-9DDC-CAF28B66A7CFQ38139834-F582A12A-5816-463E-A04B-DB85D8AC04D6Q38176678-CF62386D-E0C1-4935-BFD9-1755E57BC0F7Q38448187-615A5177-1D58-43F3-BA57-C54DE63B8D6CQ38502135-0A8763A7-46FC-4D16-9815-9A3FE4EF5763Q38612061-60726D27-C0D5-4DCB-B9D5-01EA60820277Q38668387-87D4A775-CBC9-4357-81F6-945CCDA2C6A2Q38676413-FBAE8392-CB06-4EA9-A7F1-CB01DF814C80Q38824522-3550AF3F-CB0E-4EF6-9785-402CA661EB95Q39382663-5A71E7A7-4849-456D-9146-1CD9BBF9217FQ42145272-B84A68DC-213A-4F1C-BF52-0A4BB9AA2821Q46624377-9D78EC56-DA72-40E7-AAF9-079158CBE581Q47700134-67B98B4E-DE91-467C-8A03-6F6763E50939Q47725451-68195C1F-B009-43FB-AF93-EC9CB8F0455FQ50476552-F5C95197-8D71-41BB-B8B5-428AB2A65E5BQ52332818-D6152438-39B1-4D03-8A68-20B3444DDFD3Q52334131-48312BB3-BE94-4AD0-80CE-6BC275255E51Q52591890-7B4739C1-6895-466F-AA60-20FE1DB336C2
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epigenetic mechanisms of pulmonary hypertension.
@ast
Epigenetic mechanisms of pulmonary hypertension.
@en
type
label
Epigenetic mechanisms of pulmonary hypertension.
@ast
Epigenetic mechanisms of pulmonary hypertension.
@en
prefLabel
Epigenetic mechanisms of pulmonary hypertension.
@ast
Epigenetic mechanisms of pulmonary hypertension.
@en
P2860
P356
P1476
Epigenetic mechanisms of pulmonary hypertension
@en
P2093
John J Ryan
Stephen L Archer
P2860
P304
P356
10.4103/2045-8932.87300
P577
2011-07-01T00:00:00Z